Breaking News

Trials & Filings in Brief: Nov. 21, 2013

By Gil Roth | November 21, 2013

Forest Labs, Gedeon Richter, GSK, Lundbeck, Nanotherapeutics, Otsuka, Pfizer,

Phase I
Pfizer, GSK study combo for melanoma . . . read more

Forest, Richter Schizophrenia Drug Gets CRL . . . read more

Nanotherapeutics meets with FDA over vax-facility . . . read more

Otsuka, Lundbeck monthly Abilify approved in Europe . . . read more
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.